Results 81 to 90 of about 15,628 (311)

Phase separation dynamics in colloid-polymer mixtures: the effect of interaction range

, 2012
Colloid-polymer mixtures may undergo either fluid-fluid phase separation or gelation. This depends on the depth of the quench (polymer concentration) and polymer-colloid size ratio.
Bartlett, Paul, Faers, Malcolm A., Royall, C. Patrick, Zhang, Isla   +3 more
core   +1 more source

Concordance and predictive value of two adverse drug event data sets [PDF]

, 2014
Background: Accurate prediction of adverse drug events (ADEs) is an important means of controlling and reducing drug-related morbidity and mortality.
Cami, Aurel, Reis, Ben Y
core   +1 more source

Non-chemotherapy drugs inducing agranulocytosis: a disproportionality analysis based on the FAERS database

Frontiers in Pharmacology
Introduction Non-chemotherapy drug-induced agranulocytosis (NCDIA) is a serious adverse reaction that significantly increases the risk of life-threatening infections. Although the association between certain non-chemotherapy drugs and agranulocytosis has
Shanshan Wu, Lina Huang, Jiajia Chen, Xiaochun Xie, Shaokai Huang, Xiaojie Huang   +5 more
semanticscholar   +1 more source

The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine

Clinical Pharmacology &Therapeutics, Volume 119, Issue 2, Page 318-321, February 2026.
In recent years, different national and international regulatory authorities, notably the FDA, have made their adverse event repositories publicly available, offering user‐friendly dashboards. This has led to a large increase in low‐quality, poorly reported research using adverse event reporting databases (e.g., FDA’s Adverse Event Reporting System ...
Charles Khouri, Alex Hlavaty, Michele Fusaroli, Nitin Joshi, Francesco Salvo, Andrew Bate, Antoine Pariente, Emanuel Raschi   +7 more
wiley   +1 more source

A real-world pharmacovigilance analysis of omadacycline in FDA adverse event reporting system (FAERS) database

Frontiers in Pharmacology
ObjectiveOmadacycline is a newly launched drug of tetracycline. Therefore, it is necessary to comprehensive evaluate reports on the safety of omadacycline in large, real-world populations.
Xueping Shi, Chen Wang, Xiang Liu, Li Zou, Pei Guo   +4 more
doaj   +1 more source

Fatal outcome related to drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis of FAERS database and a systematic review of cases

Frontiers in Immunology
BackgroundDrug rash with eosinophilia and systemic symptoms (DRESS) is a life-threatening severe cutaneous adverse reaction.ObjectiveThis study aims to study fatal DRESS cases using FAERS database and systematic review.MethodsData of the FDA Adverse ...
Chunsu Liang, Chunsu Liang, Pengjiao An, Pengjiao An, Yizhou Zhang, Yizhou Zhang, Xin Liu, Xin Liu, Bo Zhang, Bo Zhang   +9 more
doaj   +1 more source

Exploring Pembrolizumab‐Induced IM3OS in a Patient With Bladder Cancer

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT Pembrolizumab, an immune checkpoint inhibitor (ICI), has transformed cancer treatment across various malignancies, including metastatic urothelial cancer. As the use of pembrolizumab becomes increasingly widespread, understanding its potential adverse effects is essential.
Ching‐Cheng Chan, Ming‐Jen Lee, Jian Su, Jen‐Jen Su   +3 more
wiley   +1 more source

Risk assessment of the top 50 drugs associated with drug-induced orthostatic hypotension: a disproportionality analysis of the FAERS and JADER databases

Scientific Reports
To use the FDA Adverse Event Reporting System (FAERS) database to identify drugs associated with orthostatic hypotension. Adverse event reports of orthostatic hypotension from Q1 2004 to Q3 2024 were obtained from the FAERS and JADER databases.
Gaocan Ren, Xiansu Chi, Pingping Huang, Jinhui Zhang, Yanqiu Ding, Lijun Guo, Qinghua Shang, Xiaochang Ma   +7 more
doaj   +1 more source

Delta-8, a Cannabis-Derived Tetrahydrocannabinol Isomer: Evaluating Case Report Data in the Food and Drug Administration Adverse Event Reporting System (FAERS) Database

Drug, Healthcare and Patient Safety, 2023
Teresa A Simon,1 John H Simon,1 Erin G Heaning,1 Andres Gomez-Caminero,1 Jahan P Marcu1,2 1Physicians Research Center, LLC, Toms River, NJ, USA; 2Marcu Enterprises, Jersey City, NJ, USACorrespondence: Teresa A Simon, Physicians Research Center, LLC, Toms
Simon TA, Simon JH, Heaning EG, Gomez-Caminero A, Marcu JP   +4 more
doaj  

Roadmap to Creating a Global Health Equity Training Program Within US Anesthesiology Residency Programs

World Journal of Surgery, EarlyView.
Betelehem M. Asnake, Maziar M. Nourian, Ana M. Crawford, Bantayehu Sileshi, Sheida Tabaie   +4 more
wiley   +1 more source